Loading stock data…
OSUR
$4.24+0.09 (+2.17%)
After Hours$4.24+0.00 (+0.00%)· Last close Jun 9
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OraSure Technologies, Inc. in the Healthcare sector is trading at $4.24. Wall Street consensus targets $4.75 (2 analysts), implying a +12.0% move over the next 12 months. The stock is currently near its 52-week high of $4.33, remaining 43.7% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +12.0% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$4.24
Potential Downside
0%
Whystock Fair Value$4.24
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-23.96%
Volume
Today's trading volume
734,677
Recent News
Is Co-Diagnostics National Security’s Next Diagnostic Pick?
Global health emergencies are shifting sovereign biodefense strategies toward decentralized diagnostic networks capable of deploying rapid stockpiles.
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist
Over the last 7 days, the U.S. market has dropped by 1.0%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential is crucial for investors seeking stability and opportunity. While "penny stocks" may sound like an outdated term, they continue to represent smaller or less-established companies that can offer significant value; we've identified three such stocks...
OraSure Technologies Independent Director Acquires 195% More Stock
Investors who take an interest in OraSure Technologies, Inc. ( NASDAQ:OSUR ) should definitely note that the...
OraSure Technologies, Inc. Q1 2026 Earnings Call Summary
Moby summary of OraSure Technologies, Inc.'s Q1 2026 earnings call
OraSure Technologies Q1 Earnings Call Highlights
OraSure Technologies (NASDAQ:OSUR) reported first-quarter 2026 revenue of $27.9 million, topping the midpoint of its prior guidance range, as the company pointed to improving gross margins, ongoing cost actions, and preparations for two planned mid-year product launches that management expects to be